ACM
PVLA

Aquilo Capital Management’s Palvella Therapeutics PVLA Stock Holding History

Aquilo Capital Management’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-41,290
Closed -$984K – 15
2023
Q3 		$984K Hold
41,290
– – 0.89% 12
2023
Q2 		$547K Sell
41,290
-15,621
-27% -$947K 0.3% 13
2023
Q1 		$4.44M Hold
56,911
– – 1.84% 12
2022
Q4 		$4.73M Buy
56,911
+6,457
+13% +$519K 1.78% 13
2022
Q3 		$4.64M Buy
50,454
+3,750
+8% +$483K 1.67% 14
2022
Q2 		$6.99M Buy
46,704
+343
+0.7% +$62.6K 2.38% 10
2022
Q1 		$11.2M Buy
46,361
+6,404
+16% +$1.68M 1.65% 12
2021
Q4 		$12.1M Hold
39,957
– – 1.37% 12
2021
Q3 		$16.5M Hold
39,957
– – 3% 12
2021
Q2 		$12.2M Sell
39,957
-5,987
-13% -$1.31M 3.18% 11
2021
Q1 		$9.45M Hold
45,944
– – 1.71% 14
2020
Q4 		$9.19M Hold
45,944
– – 1.91% 13
2020
Q3 		$7.61M Sell
45,944
-23,750
-34% -$5.41M 0.81% 12
2020
Q2 		$17.3M Hold
69,694
– – 3.49% 10
2020
Q1 		$12.7M Buy
69,694
+7,609
+12% +$1.92M 4.95% 9
2019
Q4 		$17.8M Buy
62,085
+25,107
+68% +$6.96M 6.67% 4
2019
Q3 		$10.1M Buy
36,978
+18,830
+104% +$7.29M 7.1% 6
2019
Q2 		$6.82M Buy
18,148
+3,013
+20% +$899K 2.37% 11
2019
Q1 		$4.06M Hold
15,135
– – 1.8% 11
2018
Q4 		$3.22M Sell
15,135
-9,554
-39% -$2.96M 1.56% 13
2018
Q3 		$11.1M Hold
24,689
– – 4.63% 8
2018
Q2 		$10M Buy
+24,689
New +$11.7M 8.26% 5

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
1IA
1620 Investment Advisors Plymouth, Massachusetts $161M AUM 30.15% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Aquilo Capital Management's PVLA Position: Q4 2023 in Review

Aquilo Capital Management sold out of Palvella Therapeutics (PVLA) in Q4 2023, closing a stake of 41,290 shares — an estimated $984K sold.

Aquilo Capital Management first reported a position in PVLA in Q2 2018 and held it in 22 quarters. The position peaked at $17.8M in Q4 2019. 46 funds tracked by Wall St. Rank hold PVLA as of Q4 2023.

  • Aquilo Capital Management reported no remaining Palvella Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Aquilo Capital Management sold 41,290 Palvella Therapeutics shares in Q4 2023, an estimated $984K.
  • Aquilo Capital Management first reported a position in Palvella Therapeutics in Q2 2018 and held it in 22 quarters.
  • Aquilo Capital Management's Palvella Therapeutics position peaked at $17.8M in Q4 2019.
  • 46 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2023.

Based on Aquilo Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.